Trillium Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Sell
359
-6
-2% -$6.13K 0.01% 196
2026
Q1
$336K Buy
365
+6
+2% +$6.08K 0.01% 202
2025
Q4
$386K Sell
359
-85
-19% -$81.3K 0.01% 203
2025
Q3
$339K Sell
444
-3
-0.7% -$2.23K 0.01% 206
2025
Q2
$348K Buy
447
+133
+42% +$103K 0.01% 207
2025
Q1
$259K Hold
314
0.01% 217
2024
Q4
$242K Hold
314
0.01% 223
2024
Q3
$278K Sell
314
-21
-6% -$18.9K 0.01% 222
2024
Q2
$303K Hold
335
0.01% 218
2024
Q1
$261K Buy
+335
New +$238K 0.01% 224
2019
Q4
Sell
-2,002
Closed -$224K 268
2019
Q3
$224K Buy
+2,002
New +$223K 0.01% 260

Other funds holding LLY

Trillium Asset Management's LLY Position: Q2 2026 in Review

Trillium Asset Management reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $6.13K and leaving 359 shares worth $431K. The position accounts for 0.01% of the portfolio, ranked #196.

Trillium Asset Management first reported a position in LLY in Q3 2019 and has held it in 11 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Trillium Asset Management held 359 shares of Eli Lilly worth $431K as of Q2 2026.
  • Trillium Asset Management sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.01% of Trillium Asset Management's portfolio in Q2 2026, its #196 holding.
  • Trillium Asset Management first reported a position in Eli Lilly in Q3 2019 and has held it in 11 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.